Abnormal anxiety-related behavior in serotonin transporter null mutant mice: The influence of genetic background

Genes, Brain and Behavior

Volumn 2, Issue 6, 2003, Pages 365-380

  Holmes, A ^a   Li, Q ^b   Murphy, D L ^a   Gold, E ^a   Crawley, J N ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

5 HT1A receptor; Anxiety; Gene; Genetic background; Inbred strains; Mouse; Serotonin; Serotonin transporter

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ANXIETY DISORDER; ARTICLE; AUTORADIOGRAPHY; BEHAVIOR GENETICS; BRAIN TISSUE; CONGENIC STRAIN; CONTROLLED STUDY; DECAPITATION; EXPLORATORY BEHAVIOR; FEMALE; GENE MUTATION; GENE REPRESSION; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC VARIABILITY; HYPOTHERMIA; MALE; MAZE TEST; MENTAL DISEASE; MOOD; MORPHOLOGICAL TRAIT; MOUSE; MOUSE MUTANT; MUTATIONAL ANALYSIS; NEWBORN; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; RECEPTOR BINDING; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; STRAIN DIFFERENCE;

ANIMALS; ANXIETY; ANXIETY DISORDERS; BRAIN CHEMISTRY; CARRIER PROTEINS; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; FEMALE; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, KNOCKOUT; MICE, MUTANT STRAINS; NERVE TISSUE PROTEINS; PENETRANCE; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

ANIMALIA;

EID: 0345305849     PISSN: 16011848     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1601-1848.2003.00050.x     Document Type: Article

References (104)

1. Arango, V., Underwood, M.D., Boldrini, M., Tamir, H., Kassir, S.A., Hsiung, S., Chen, J.J. & Mann, J.J. (2001) Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology 25, 892-903.
2. Bale, T.L., Picetti, R., Contarino, A., Koob, G.F., Vale, W.W. & Lee, K.F. (2002) Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior. J Neuroscience 22, 193-199.
3. Ballenger, J.C. (1999) Current treatments of the anxiety disorders in adults. Biol Psychiatry 46, 1579-1594.
4. Banbury Conference on Genetic Background in Mice (1997) Mutant mice and neuroscience: recommendations concerning genetic background. Neuron 19, 755-759.
5. Barr, C., Newman, T., Becker, M., Parker, C., Champoux, M., Lesch, K.P., Goldman, D., Suomi, S. & Higley, J.D. (2003) Early experience and rh5-HTTLPR genotype interact to influence social behavior and aggression in nonhuman primates. Genes, Brain Behav 2, 336-340.
6. Bengel, D., Murphy, D.L., Andrews, A.M., Wichems, C.H., Feltner, D., Heils, A., Mossner, R., Westphal, H. & Lesch, K.P. (1998) Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ('Ecstasy') in serotonin transporter-deficient mice. Mol Pharmacol 53, 649-655.
7. Bergman, A. & Siegal, M.L. (2003) Evolutionary capacitance as a general feature of complex gene networks. Nature 424, 549-552.
8. Blakely, R.D., Berson, H.E., Fremeau, R.T. Jr, Caron, M.G., Peek, M.M., Prince, H.K. & Bradley, C.C. (1991) Cloning and expression of a functional serotonin transporter from rat brain. Nature 354, 66-70.
9. Bolivar, V.J., Caldarone, B.J., Reilly, A.A. & Flaherty, L. (2000) Habituation of activity in an open field: a survey of inbred strains and F1 hybrids. Behav Genet 30, 285-293.
10. Bolivar, V.J., Cook, M.N. & Flaherty, L. (2001) Mapping of quantitative trait loci with knockout/congenic strains. Genome Res 11, 1549-1552.
11. Bowers, B.J., Owen, E.H., Collins, A.C., Abeliovich, A., Tonegawa, S. & Wehner, J.M. (1999) Decreased ethanol sensitivity and tolerance development in gamma-protein kinase C null mutant mice is dependent on genetic background. Alcoholism: Clin Exp Res 23, 387-397.
12. Briley, M.S., Langer, S.Z., Raisman, R., Sechter, D. & Zarifian, E. (1980) Tritiated imipramine binding sites are decreased in platelets of untreated depressed patients. Science 209, 303-305.
13. Caldarone, B.J., George, T.P., Zachariou, V. & Picciotto, M.R. (2000) Gender differences in learned helplessness behavior are influenced by genetic background. Pharmacology, Biochem Behav 66, 811-817.
14. Caspi, A., Sugden, K., Moffitt, T.E., Taylor, A., Craig, I.W., Harrington, H.L., McClay, J., Mill, J., Martin, J., Braithwaite, A. & Poulto, R. (2003) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301, 386-389.
15. Contet, C., Rawlins, J.N. & Deacon, R.M. (2001) A comparison of 129S2/SvHsd and C57BL/6JOlaHsd mice on a test battery assessing sensorimotor, affective and cognitive behaviours: implications for the study of genetically modified mice. Behav Brain Res 124, 33-46.
16. Cook, M.N., Bolivar, V.J., McFadyen, M.P. & Flaherty, L. (2002) Behavioral differences among 129 substrains: implications for knockout and transgenic mice. Behav Neuroscience 116, 600-611.
17. Crabbe, J.C. (2001) Use of genetic analyses to refine phenotypes related to alcohol tolerance and dependence. Alcoholism: Clin Exp Res 25, 288-292.
18. Crabbe, J.C., Wahlsten, D. & Dudek, B.C. (1999) Genetics of mouse behavior: interactions with laboratory environment. Science 284, 1670-1672.
19. Crawley, J.N. (1981) Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines. Pharmacology, Biochem Behav 15, 695-699.
20. Crawley, J.N. (2000) What's Wrong with My Mouse? Behavioral Phenotyping of Transgenic and Knockout Mice. Wiley-Liss, New York.
21. Crawley, J.N., Belknap, J.K., Collins, A., Crabbe, J.C., Frankel, W., Henderson, N., Hitzemann, R.J., Maxson, S.C., Miner, L.L., Silva, A.J., Wehner, J.M., Wynshaw-Boris, A. & Paylor, R. (1997) Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology 132, 107-124.
22. Crestani, F., Lorez, M., Baer, K., Essrich, C., Benke, D., Laurent, J.P., Belzung, C., Fritschy, J.M., Luscher, B. & Mohler, H. (1999) Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues. Nature Neuroscience 2, 833-839.
23. Crusio, W.E. (1996) Gene-targeting studies: new methods, old problems. Trends Neurosciences 19, 186-187.
24. Dawson, G.R., Crawford, S.P., Stanhope, K.J., Iversen, S.D. & Tricklebank, M.D. (1994) One-trial tolerance to the effects of chlordiazepoxide on the elevated plus maze may be due to locomotor habituation, not repeated drug exposure. Psychopharmacology 113, 570-572.
25. Fabre, V., Beaufour, C., Evrard, A., Rioux, A., Hanoun, N., Lesch, K.P., Murphy, D.L., Lanfumey, L., Hamon, M. & Martres, M.P. (2000) Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter. European J Neuroscience 12, 2299-2310.
26. File, S.E. (2001) Factors controlling measures of anxiety and responses to novelty in the mouse. Behav Brain Res 125, 151-157.
27. Flint, J. (2003) Analysis of quantitative trait loci that influence animal behavior. J Neurobiol 54, 46-77.
28. Franklin, K.B.J. & Paxinos, G. (1997) The Mouse Brain in Stereotaxic Coordinates. Academic Press, San Diego.
29. Gerlai, R. (1996) Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype? Trends Neurosciences 19, 177-181.
30. Gobbi, G., Murphy, D.L., Lesch, K.P. & Blier, P. (2001) Modifications of the serotonergic system in mice lacking serotonin transporters: an in vivo electrophysiological study. J Pharmacol Exp Therapeutics 296, 987-995.
31. Graves, L., Dalvi, A., Lucki, I., Blendy, J.A. & Abel, T. (2002) Behavioral analysis of CREB alphadelta mutation on a B6/129, F1 hybrid background. Hippocampus 12, 18-26.
32. Greenberg, B.D., Li, Q., Lucas, F.R., Hu, S., Sirota, L.A., Benjamin, J., Lesch, K.P., Hamer, D. & Murphy, D.L. (2000) Association between the serotonin transporter promoter polymorphism and personality traits in a primarily female population sample. Am J Med Genet 96, 202-216.
33. Greenberg, B.D., Tolliver, T.J., Huang, S.J., Li, Q., Bengel, D. & Murphy, D.L. (1999) Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet 88, 83-87.
34. Griebel, G., Rodgers, R.J., Perrault, G. & Sanger, D.J. (2000) The effects of compounds varying in selectivity as 5-HT (1A) receptor antagonists in three rat models of anxiety. Neuropharmacology 39, 1848-1857.
35. Hariri, A.R., Mattay, V.S., Tessitore, A., Fera, F., Goldman, D., Egan, M.F. & Weinberger, D.R. (2002) Serotonin transporter genetic variation and the response of the human amygdala. Science 297, 400-403.
36. Hariri, A.R. & Weinberger, D.R. (2003) Functional neuroimaging of genetic variation in serotonergic neurotransmission. Genes, Brain Behav 2, 341-349.
37. Heinz, A., Higley, J.D., Gorey, J.G., Saunders, R.C., Jones, D.W., Hommer, D., Zajicek, K., Suomi, S.J., Lesch, K.P., Weinberger, D.R. & Linnoila, M. (1998) In vivo association between alcohol intoxication, aggression, and serotonin transporter availability in nonhuman primates. Am J Psychiatry 155, 1023-1028.
38. Heisler, L.K., Chu, H.-M., Brennan, T.J., Danao, J.A., Bajwa, P., Parson, L.H. & Tecott, L.H. (1998) Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proc Natl Acad Sci USA 95, 15 049-15 054.
39. Holmes, A. (2001) Targeted gene mutation approaches to the study of anxiety-like behavior in mice. Neuroscience & Biobehavioral Rev 25, 261-273.
40. Holmes, A., Kinney, J.W., Wrenn, C.C., Li, Q., Yang, R.J., Ma, L., Vishwanath, J., Saveedra, M.C., Innerfield, C.E., Jacoby, A.S., Shine, J., Iismaa, T.P. & Crawley, J.N. (2003a) Galanin GAL-R1 receptor null mutant mice display increased anxiety-like behavior specific to the elevated plus-maze test. Neuropsychopharmacology 28, 1031-1044.
41. Holmes, A., Murphy, D.L. & Crawley, J.N. (2002a) Reduced aggression in mice lacking the 5-HT transporter. Psychopharmacology 161, 160-167.
42. Holmes, A., Murphy, D.L. & Crawley, J.N. (2003c) Behavioral phenotypes of serotonin transporter knockout mice; parallels with human anxiety and depression. Biol Psych in press.
43. Holmes, A., Parmigiani, S., Ferrari, P.F., Palanza, P. & Rodgers, R.J. (2000) Behavioral profile of wild mice in the elevated plus-maze test for anxiety. Physiol Behav 71, 509-516.
44. Holmes, A. & Rodgers, R.J. (1998) Responses of Swiss-Webster mice to repeated plus-maze experience: further evidence for a qualitative shift in emotional state? Pharmacology, Biochem Behav 60, 473-488.
45. Holmes, A., Wrenn, C.C., Harris, A.P., Thayer, K., & Crawley, J.N. (2002b) Behavioral profiles of inbred strains on novel olfactory, spatial and emotional tests for reference memory in mice. Genes, Brain Behav 1, 55-69.
46. 1A receptor-mediated abnormalities in anxiety-like and exploratory behavior. Neuropsychopharmacology doi: 10.1016/S0893-133X(02)00374-3.
47. Holmes, A., Yang, R.J., Murphy, D.L. & Crawley, J.N. (2001) Genetic background determines behavioral phenotypes in serotonin transporter knockout mice. International Behavioural and Neural Genetics Society Annual Meeting, San Diego, USA.
48. Holmes, A., Yang, R.J., Murphy, D.L. & Crawley, J.N. (2002d) Evaluation of antidepressant-related behavioral responses in mice lacking the serotonin transporter. Neuropsychopharmacology 27, 914-923.
49. Homanics, G.E., Quinlan, J.J. & Firestone, L.L. (1999) Pharmacologic and behavioral responses of inbred C57BL/6J and strain 129/SvJ mouse lines. Pharmacology, Biochem Behav 63, 21-26.
50. Hood, H.M., Belknap, J.K., Crabbe, J.C. & Buck, K.J. (2001) Genomewide search for epistasis in a complex trait: pentobarbital withdrawal convulsions in mice. Behav Genet 31, 93-100.
51. Jacobsen, L.K., Staley, J.K., Zoghbi, S.S., Seibyl, J.P., Kosten, T.R., Innis, R.B. & Gelernter, J. (2000) Prediction of dopamine transporter binding availability by genotype: a preliminary report. Am J Psychiatry 157, 1700-1703.
52. Kelly, M.A., Rubinstein, M., Phillips, T.J., Lessov, C.N., Burkhart-Kasch, S., Zhang, G., Bunzow, J.R., Fang, Y., Gerhardt, G.A., Grandy, D.K. & Low, M.J. (1998) Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations. J Neuroscience 18, 3470-3479.
53. Kendler, K.S. (2001) Twin studies of psychiatric illness: an update. Arch General Psychiatry 58, 1005-1014.
54. Kugaya, A., Seneca, N.M., Snyder, P.J., Williams, S.A., Malison, R.T., Baldwin, R.M., Seibyl, J.P. & Innis, R.B. (2003) Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administration. Neuropsychopharmacology 28, 413-420.
55. Le Roy, I., Pothion, S., Mortaud, S., Chabert, C., Nicolas, L., Cherfouh, A. & Roubertoux, P.L. (2000) Loss of aggression, after transfer onto a C57BL/6J background, in mice carrying a targeted disruption of the neuronal nitric oxide synthase gene. Behav Genet 30, 367-373.
56. Lesch, K.P. (2001) Molecular foundation of anxiety disorders. J Neural Transmission 108, 717-746.
57. Lesch, K.P., Bengel, D., Heils, A., Sabol, S.Z., Greenberg, B.D., Petri, S., Benjamin, J., Muller, C.R., Hamer, D.H. & Murphy, D.L. (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274, 1527-1531.
58. Lesch, K.P. & Mossner, R. (1998) Genetically driven variation in serotonin uptake: is there a link to affective spectrum, neurodevelopmental and neurodegenerative disorders? Biol Psychiatry 44, 179-192.
59. Li, Q., Wichems, C., Heils, A., Lesch, K.P. & Murphy, D.L. (2000) Reduction in the density and expression, but not G-protein coupling, of serotonin receptors (5-HT1A) in 5-HT transporter knock-out mice, gender and brain region differences. J Neuroscience 20, 7888-7895.
60. Li, Q., Wichems, C., Heils, A., Van de Kar, L.D., Lesch, K.P. & Murphy, D.L. (1999) Reduction of 5-hydroxytryptamine (5-HT) (1A) -mediated temperature and neuroendocrine responses and 5-HT (1A) binding sites in 5-HT transporter knockout mice. J Pharmacol Exp Therapeutics 291, 999-1007.
61. Little, K.Y., McLaughlin, D.P., Zhang, L., Livermore, C.S., Dalack, G.W., De McFinton, P.R.I., Proposto, Z.S., Hill, E., Cassin, B.J., Watson, S.J. & Cook, E.H. (1998) Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels. Am J Psychiatry 155, 207-213.
62. Logue, S.F., Owen, E.H., Rasmussen, D.L. & Wehner, J.M. (1997) Assessment of locomotor activity, acoustic and tactile startle, and prepulse inhibition of startle in inbred mouse strains and F1 hybrids: implications of genetic background for single gene and quantitative trait loci analyses. Neuroscience 80, 1075-1086.
63. Malison, R.T., Price, L.H., Berman, R., van Dyck, C.H., Pelton, G.H., Carpenter, L., Sanacora, G., Owens, M.J., Nemeroff, C.B., Rajeevan, N., Baldwin, R.M., Seibyl, J.P., Innis, R.B. & Charney, D.S. (1998) Reduced brain serotonin transporter availability in major depression as measured by [1231]-2 betacarbomethoxy-3 beta-(4-iodophenyl) tropane and single photon emission computed tomography. Biol Psychiatry 44, 1090-1098.
64. Mann, J.J., Huang, Y.Y., Underwood, M.D., Kassir, S.A., Oppenheim, S., Kelly, T.M., Dwork, A.J. & Arango, V.A. (2000) Serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch General Psychiatry 57, 729-738.
65. Mannoury la Cour, C., Boni, C., Hanoun, N., Lesch, K.P., Hamon, M. & Lanfumey, L. (2001) Functional consequences of 5-HT transporter gene disruption on 5-HT (1a) receptor-mediated regulation of dorsal raphe and hippocampal cell activity. J Neuroscience 21, 2178-2185.
66. Marsh, D.J., Baraban, S.C., Hollopeter, G., & Palmiter, R.D. (1999) Role of the Y5 neuropeptide Y receptor in limbic seizures. Proc Natl Acad Sci USA 96, 13518-13523.
67. Mathis, C., Neumann, P.E., Gershenfeld, H., Paul, S.M. & Crawley, J.N. (1995) Genetic analysis of anxiety-related behaviors and responses to benzodiazepine-related drugs in AXB and BXA recombinant inbred mouse strains. Behav Genet 25, 557-568.
68. Mazzanti, C.M., Lappalainen, J., Long, J.C., Bengel, D., Naukkarinen, H., Eggert, M., Virkkunen, M., Linnoila, M. & Goldman, D. (1998) Role of the serotonin transporter promoter polymorphism in anxiety-related traits. Arch General Psychiatry 55, 936-940.
69. McIlwain, K.L., Merriweather, M.Y., Yuva-Paylor, L.A. & Paylor, R. (2001) The use of behavioral test batteries: effects of training history. Physiol Behav 73, 705-717.
70. McNamara, F.N., Clifford, J.J., Tighe, O., Kinsella, A., Drago, J., Croke, D.T. & Waddington, J.L. (2003) Congenic D1A dopamine receptor mutants: ethologically based resolution of behavioural topography indicates genetic background as a determinant of knockout phenotype. Neuropsychopharmacology 28, 86-99.
71. Montkowski, A., Poettig, M., Mederer, A. & Holsboer, F. (1997) Behavioural performance in three substrains of mouse strain 129. Brain Res 762, 12-18.
72. Murphy, D.L., Holmes, A., Ren-Patternson, R., Uhl, G. & Lesch, K.P. (2003) Experimental single gene x single gene and gene x environment studies with serotonin transporter mutant mice as models for human polygenic traits and disorders. Genes, Brain Behav 2, 350-364.
73. Murphy, D.L., Li, Q., Engel, S., Wichems, C., Andrews, A., Lesch, K.P. & Uhl, G. (2001) Genetic perspectives on the serotonin transporter. Brain Res Bull 56, 487-494.
74. Nadeau, J.H. (2001) Modifier genes in mice and humans. Nature Rev Genet 2, 165-174.
75. Naylor, L., Dean, B., Pereira, A., Mackinnon, A., Kouzmenko, A. & Copolov, D. (1998) No association between the serotonin transporter-linked promoter region polymorphism and either schizophrenia or density of the serotonin transporter in human hippocampus. Mol Med 4, 671-674.
76. Nemeroff, C.B., Knight, D.L., Franks, J., Craighead, W.E. & Krishnan, K.R. (1994) Further studies on platelet serotonin transporter binding in depression. Am J Psychiatry 151, 1623-1625.
77. Olivier, B., Pattij, T., Wood, S.J., Oosting, R., Sarnyai, Z. & Toth, M. (2001) The 5-HT (1A) receptor knockout mouse and anxiety. Behav Pharmacol 12, 439-450.
78. Olivier, B., Zethof, T., Pattij, T., van Boogaert, M., van Oorschot, R., Leahy, C., Oosting, R., Bouwknecht, A., Veening, J., van der Gugten, J. & Groenink, L. (2003) Stress-induced hyperthermia and anxiety: pharmacological validation. European J Pharmacol 463, 117-132.
79. Parks, C.L., Robinson, P.S., Sibille, E., Shenk, T. & Toth, M. (1998) Increased anxiety of mice lacking the serotonin 1A receptor. Proc Natl Acad Sci USA 95, 10734-10739.
80. Phillips, T.J., Hen, R. & Crabbe, J.C. (1999) Complications associated with genetic background effects in research using knockout mice. Psychopharmacology 147, 5-7.
81. Plomin, R., Owen, M.J. & McGuffin, P. (1994) The genetic basis of complex human behaviors. Science 264, 1733-1739.
82. Ramamoorthy, S., Bauman, A.L., Moore, K.R., Han, H., Yang-Feng, T., Chang, A.S., Ganapathy, V. & Blakely, R.D. (1993) Antidepressant- and cocaine-sensitive human serotonin transporter, molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci USA 90, 2542-2546.
83. Ramboz, S., Oosting, R., Amara, D.A., Kung, H.F., Blier, P., Mendelsohn, M., Mann, J.J., Brunner, D. & Hen, R. (1998) Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proc Natl Acad Sci USA 95, 14476-14481.
84. Rodgers, R.J., Boullier, E., Chatzimichalaki, P., Cooper, G.D. & Shorten, A. (2002a) Contrasting phenotypes of C57BL/6JOlaHsd, 129S2/SvHsd and 129/SvEv mice in two exploration-based tests of anxiety-related behaviour. Physiol Behav 77, 301-310.
85. Rodgers, R.J., Davies, B. & Shore, R. (2002b) Absence of anxiolytic response to chlordiazepoxide in two common background strains exposed to the elevated plus-maze: importance and implications of behavioural baseline. Genes, Brain Behav 1, 242-251.
86. Rodgers, R.J., Haller, J., Halasz, J. & Mikics, E. (2003) 'One-trial sensitization' to the anxiolytic-like effects of cannabinoid receptor antagonist SR141716A in the mouse elevated plus-maze. European J Neuroscience 17, 1279-1286.
87. Rogers, D.C., Jones, D.N., Nelson, P.R., Jones, C.M., Quilter, C.A., Robinson, T.L. & Hagan, J.J. (1999) Use of SHIRPA and discriminant analysis to characterise marked differences in the behavioural phenotype of six inbred mouse strains. Behav Brain Res 105, 207-217.
88. Rubinsztein, D.C. (2002) Lessons from animal models of Huntington's disease. Trends Genet 18, 202-209.
89. Shioe, K., Ichimiya, T., Suhara, T., Takano, A., Sudo, Y., Yasuno, F., Hirano, M., Shinohara, M., Kagami, M., Okubo, Y., Nankai, M. & Kanba, S. (2003) No association between genotype of the promoter region of serotonin transporter gene and serotonin transporter binding in human brain measured by PET. Synapse 15, 184-188.
90. Simpson, E.M., Linder, C.C., Sargent, E.E., Davisson, M.T., Mobraaten, L.E. & Sharp, J.J. (1997) Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice. Nature Genet 16, 19-27.
91. Sora, I., Hall, F.S., Andrews, A.M., Itokawa, M., Li, X.F., Wei, H.B., Wichems, C., Lesch, K.P., Murphy, D.L. & Uhl, G.R. (2001) Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. Proc Natl Acad Sci USA 98, 5300-5305.
92. Stein, D.J. & Berk, M. (2000) Selective serotonin reuptake inhibitors in the anxiety disorders. Int Clin Psychopharmacol S15, 1-63.
93. Stoltenberg, S.F. & Hirsch, J. (1997) Y-chromosome effects on Drosophila geotaxis interact with genetic or cytoplasmic background. Anim Behav 53, 853-864.
94. Thiele, T.E., Miura, G.I., Marsh, D.J., Bernstein, I.L. & Palmiter, R.D. (2000) Neurobiological responses to ethanol in mutant mice lacking neuropeptide Y or the Y5 receptor. Pharmacology, Biochem Behav 67, 683-691.
95. Tjurmina, O.A., Armando, I., Saavedra, J.M., Goldstein, D.S. & Murphy, D.L. (2002) Exaggerated adrenomedullary response to immobilization in mice with targeted disruption of the serotonin transporter gene. Endocrinology 143, 4520-4526.
96. Tsuji, M., Takeda, H. & Matsumiya, T. (2000) Different effects of 5-HT1A receptor agonists and benzodiazepine anxiolytics on the emotional state of naive and stressed mice: a study using the hole-board test. Psychopharmacology 152, 157-166.
97. Turri, M.G., Datta, S.R., DeFries, J., Henderson, N.D. & Flint, J. (2001) QTL analysis identifies multiple behavioral dimensions in ethological tests of anxiety in laboratory mice. Current Biol 11, 725-734.
98. Vogel, C., Mossner, R., Gerlach, M., Heinemann, T., Murphy, D.L. & Riederer, P. (2003) Absence of thermal hyperalgesia in serotonin transporter-deficient mice. J Neuroscience 23, 708-715.
99. Voikar, V., Koks, S., Vasar, E. & Rauvala, H. (2001) Strain and gender differences in the behavior of mouse lines commonly used in transgenic studies. Physiol Behav 72, 271-281.
100. Willeit, M., Praschak-Rieder, N., Neumeister, A., Pirker, W., Asenbaum, S., Vitouch, O., Tauscher, J., Hilger, E., Stastny, J., Brucke, T. & Kasper, S. (2000) [1231]-beta-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder. Biol Psychiatry 47, 482-489.
101. Wisor, J.P., Wurts, S.W., Hall, F.S., Lesch, K.P., Murphy, D.L. & Uhl, G.R. (2003) Altered rapid eye movement sleep timing in serotonin transporter knockout mice. Neuroreport 14, 233-238.
102. Wolfer, D.P., Crusio, W.E. & Lipp, H.P. (2002) Knockout mice: simple solutions to the problems of genetic background and flanking genes. Trends Neurosciences 25, 336-340.
103. Wolfer, D.P. & Lipp, H.P. (2000) Dissecting the behaviour of transgenic mice: is it the mutation, the genetic background, or the environment? Exp Physiol 85, 627-634.
104. Wolfer, D.P., Muller, U., Stagliar, M. & Lipp, H.P. (1997) Assessing the effects of the 129/Sv genetic background on swimming navigation learning in transgenic mutants: a study using mice with a modified beta-amyloid precursor protein gene. Brain Res 771, 1-13.